Prevalence,Natural History,Prognosis Factor,QualityofLife,Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France
KHOALA
Knee and Hip OsteoArthritis Long Term Assessment. Prevalence, Natural History, Prognosis Factor, Quality of Life, Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France
1 other identifier
interventional
878
1 country
6
Brief Summary
The aim of the project is to assemble and to follow on a 10-year period a nationwide representative sample of lower limb OA patients. General objectives: To document the natural history and to identify predictive factors of the evolution and consequences of hip and knee OA in terms of pain, functional disability, structural damage, quality of life, autonomy, medical and health care use and cost of disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2007
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 31, 2007
CompletedFirst Posted
Study publicly available on registry
June 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedAugust 3, 2015
July 1, 2015
11.9 years
May 31, 2007
July 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life, patient reported outcome measures
every year, up to 10 years
Secondary Outcomes (1)
health care consumption
every year, up to 10 years
Study Arms (1)
Study specific procedure
EXPERIMENTALX-rays, biological samples and medical information about osteoarthritis
Interventions
biological sample (blood and urine) every 2 years
several questionnaires about pain and function (WOMAC), physical activity (MAQ), quality of life (generic SF-36 and OA specific OAKHQOL/AMIQUAL), comorbidities (FCI), mental status (MMS), heath status (GHQ 28) and health resource consumption
Eligibility Criteria
You may qualify if:
- male and female aged between 40 and 75 years
- symptomatic hip or knee, uni or bilateral OA with clinical diagnosis confirmed by a medical physician and satisfying ACR classification criteria
- Representative of prevalent cases in France at the cohort set-up time
You may not qualify if:
- presence of hip or knee joint replacement surgery
- comorbidities severe enough to affect quality of life significantly or likely to induce a high health care consumption independently of OA
- an history of osteotomy
- Patello-femoral osteoarthritis without tibio-femoral osteoarthritis
- Other joint diseases of the target joints
- adult under legal protection or not able to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Patrice Fardellone
Amiens, France
CHU de la Cavale Blanche
Brest, 29609, France
CHU Nancy, hopital brabois
Nancy, 54035, France
CHU l'Archet
Nice, 06202, France
Hôpital de la Pitié-Salpêtrière
Paris, 75651, France
CHU Rangueil
Toulouse, 31059, France
Related Publications (1)
Garnero P, Guillemin F, Ngueyon Sime W, Gineyts E, Chapurlat R, Roux C. Cartilage turnover, but not novel synovial collagen marker, is associated with joint damage progression in osteoarthritis patients. Rheumatology (Oxford). 2025 Sep 26:keaf510. doi: 10.1093/rheumatology/keaf510. Online ahead of print.
PMID: 41002273DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francis Guillemin, MD, PhD
CHU Nancy (promoteur)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2007
First Posted
June 1, 2007
Study Start
April 1, 2007
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
August 3, 2015
Record last verified: 2015-07